valproic acid has been researched along with Leukemia, T-Cell in 4 studies
Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
Leukemia, T-Cell: A malignant disease of the T-LYMPHOCYTES in the bone marrow, thymus, and/or blood.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yang, H | 1 |
Hoshino, K | 1 |
Sanchez-Gonzalez, B | 1 |
Kantarjian, H | 1 |
Garcia-Manero, G | 1 |
Rezácová, M | 3 |
Vávrová, J | 3 |
Vokurková, D | 3 |
Záskodová, D | 3 |
Tichy, A | 1 |
Janovská, S | 1 |
Hernychová, L | 1 |
Tichá, Z | 1 |
Lukásová, E | 1 |
4 other studies available for valproic acid and Leukemia, T-Cell
Article | Year |
---|---|
Antileukemia activity of the combination of 5-aza-2'-deoxycytidine with valproic acid.
Topics: Antibiotics, Antineoplastic; Apoptosis; Azacitidine; Cell Line, Tumor; Decitabine; DNA Primers; Drug | 2005 |
Effect of valproic acid and antiapoptotic cytokines on differentiation and apoptosis induction of human leukemia cells.
Topics: Annexin A5; Antigens, CD; Apoptosis; Apoptosis Regulatory Proteins; Cell Differentiation; Cell Survi | 2006 |
Effect of valproic acid, a histone deacetylase inhibitor, on cell death and molecular changes caused by low-dose irradiation.
Topics: Apoptosis; Cell Line, Tumor; Dose-Response Relationship, Radiation; Gamma Rays; Histone Deacetylase | 2006 |
Proteomic analysis of MOLT-4 cells treated by valproic acid.
Topics: Annexin A5; Apoptosis; Cell Survival; Electrophoresis, Gel, Two-Dimensional; Enzyme Inhibitors; Flow | 2007 |